Imperial College London
Alternate

Professor Neil Poulter

Faculty of Medicine, School of Public Health

Professor of Preventive Cardiovascular Medicine.
 
 
 
//

Contact

 

+44 (0)20 7594 3446n.poulter

 
 
//

Assistant

 

Mrs Ranjit Rayat +44 (0)20 7594 3445

 
//

Location

 

55Stadium HouseWhite City Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Beaney:2019:eurheartj/ehz300,
author = {Beaney, T and Burrell, LM and Castillo, RR and Charchar, FJ and Cro, S and Damasceno, A and Kruger, R and Nilsson, PM and Prabhakaran, D and Ramirez, AJ and Schlaich, MP and Schutte, AE and Tomaszewski, M and Touyz, R and Wang, J-G and Weber, MA and Poulter, NR and MMM, Investigators},
doi = {eurheartj/ehz300},
journal = {European Heart Journal},
pages = {2006--2017},
title = {May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension},
url = {http://dx.doi.org/10.1093/eurheartj/ehz300},
volume = {40},
year = {2019}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - AIMS: Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide and fewer than half of those with hypertension are aware of it. May Measurement Month (MMM) is a global campaign set up in 2017, to raise awareness of high BP and as a pragmatic solution to a lack of formal screening worldwide. The 2018 campaign was expanded, aiming to include more participants and countries. METHODS AND RESULTS: Eighty-nine countries participated in MMM 2018. Volunteers (≥18 years) were recruited through opportunistic sampling at a variety of screening sites. Each participant had three BP measurements and completed a questionnaire on demographic, lifestyle, and environmental factors. Hypertension was defined as a systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg, or taking antihypertensive medication. In total, 74.9% of screenees provided three BP readings. Multiple imputation using chained equations was used to impute missing readings. 1 504 963 individuals (mean age 45.3 years; 52.4% female) were screened. After multiple imputation, 502 079 (33.4%) individuals had hypertension, of whom 59.5% were aware of their diagnosis and 55.3% were taking antihypertensive medication. Of those on medication, 60.0% were controlled and of all hypertensives, 33.2% were controlled. We detected 224 285 individuals with untreated hypertension and 111 214 individuals with inadequately treated (systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg) hypertension. CONCLUSION: May Measurement Month expanded significantly compared with 2017, including more participants in more countries. The campaign identified over 335 000 adults with untreated or inadequately treated hypertension. In the absence of systematic screening programmes, MMM was effective at raising awareness at least among these individuals at risk.
AU  - Beaney,T
AU  - Burrell,LM
AU  - Castillo,RR
AU  - Charchar,FJ
AU  - Cro,S
AU  - Damasceno,A
AU  - Kruger,R
AU  - Nilsson,PM
AU  - Prabhakaran,D
AU  - Ramirez,AJ
AU  - Schlaich,MP
AU  - Schutte,AE
AU  - Tomaszewski,M
AU  - Touyz,R
AU  - Wang,J-G
AU  - Weber,MA
AU  - Poulter,NR
AU  - MMM,Investigators
DO  - eurheartj/ehz300
EP  - 2017
PY  - 2019///
SN  - 1522-9645
SP  - 2006
TI  - May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension
T2  - European Heart Journal
UR  - http://dx.doi.org/10.1093/eurheartj/ehz300
UR  - https://www.ncbi.nlm.nih.gov/pubmed/31041440
UR  - http://hdl.handle.net/10044/1/70624
VL  - 40
ER  -
Download